G&E Herbal Biotechnology Co., Ltd.

Taipei Exchange 4911.TWO

G&E Herbal Biotechnology Co., Ltd. Gross Profit for the year ending December 31, 2023: USD 4.71 M

G&E Herbal Biotechnology Co., Ltd. Gross Profit is USD 4.71 M for the year ending December 31, 2023, a 266.87% change year over year. Gross profit is the difference between revenue and the cost of revenue, representing the profit earned from core business operations.
  • G&E Herbal Biotechnology Co., Ltd. Gross Profit for the year ending December 31, 2022 was USD 1.28 M, a 269.74% change year over year.
  • G&E Herbal Biotechnology Co., Ltd. Gross Profit for the year ending December 31, 2021 was USD 347.21 K, a -18.71% change year over year.
  • G&E Herbal Biotechnology Co., Ltd. Gross Profit for the year ending December 31, 2020 was USD 427.12 K, a 321.09% change year over year.
  • G&E Herbal Biotechnology Co., Ltd. Gross Profit for the year ending December 31, 2019 was USD -193.19 K.
Key data
Date Gross Profit Operating Income EBIT EBITDA
Market news
Loading...
Taipei Exchange: 4911.TWO

G&E Herbal Biotechnology Co., Ltd.

CEO Mr. Kou-Wha Kou Ph.D.
IPO Date March 21, 2011
Location
Headquarters No.92, Keji 5th Road
Employees 37
Sector Health Care
Industries
Description

G&E Herbal Biotechnology Co., Ltd., a biopharmaceutical company, focuses on the development and commercialization of novel botanical extraction technology and products. It offers botanical anti-aging cosmetic products, such as facial foam cleanser and cleansing essence, botanical extract toner, lightening lotion, essential oil, and moisturizing serum and cream; SR-100 botanical essence and bromelain illuminating cleansing mousse; and hepato protective agent capsules. The company also provides botanical healthcare products comprising ArthrEnergy, Jujubes Polysaccharide, Diabecut, HepatoClean, Astragali Radix, Goji, Prosta, and SR-100 capsules; and adult products. In addition, it is developing Solarise injection for the treatment of gynecologic, head, and neck cancer; Apocin capsule to treat non-small cell lung cancer; and SR-T100 Gel for the treatment of common and genital warts. Further, the company manufactures technology development for various dietary supplements, as well as provides technical advisory services to other biotechnology organizations. G&E Herbal Biotechnology Co., Ltd. was founded in 2002 and is based in Tainan City, Taiwan.

StockViz Staff

January 15, 2025

Any question? Send us an email